Table 1 B7-H5 expression and clinical features in 87 colorectal cancer patient samples.
From: B7-H5 blockade enhances CD8+ T-cell-mediated antitumor immunity in colorectal cancer
Characteristic | Total no. | B7-H5 expression | P value | |||
|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | |||
All cases | 87 | 2 | 36 | 27 | 22 | |
Age | ||||||
<70 | 37 | 0 | 18 | 11 | 8 | |
≥70 | 50 | 2 | 18 | 16 | 14 | |
Gender | 0.292 | |||||
Male | 46 | 1 | 20 | 17 | 8 | |
Female | 41 | 1 | 16 | 10 | 14 | |
Tumor depth | 0.243 | |||||
T1/T2 | 6 | 0 | 1 | 3 | 2 | |
T3/T4 | 81 | 2 | 35 | 24 | 20 | |
LN involvement | 0.036 | |||||
N0 | 53 | 1 | 26 | 18 | 9 | |
N1/N2 | 34 | 1 | 10 | 11 | 13 | |
Pathological grading | 0.51 | |||||
Moderate | 48 | 1 | 23 | 11 | 13 | |
Poor | 39 | 1 | 13 | 18 | 9 | |
AJCC stage | 0.037 | |||||
I/II | 53 | 1 | 26 | 17 | 9 | |
III/IV | 34 | 1 | 10 | 10 | 13 | |
Death | 0.026 | |||||
− | 35 | 0 | 22 | 6 | 7 | |
+ | 52 | 2 | 14 | 21 | 15 | |